Clinical and Ultrasonographic Predictors of IUD Related Complications

NCT ID: NCT06806358

Last Updated: 2025-03-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-01

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* All patients fulfilling the selection criteria undergo complete clinical examination and detailed medical history obtained. Each patient had a Case Record Form (CRF) recording participants' name. number, previous deliveries and abortions, age, height, weight, BMI, LMP, past medical and surgical history and contraceptive history.
* All participants will be subjected to transvaginal ultrasound to measure uterine size, endometrial and myometrial thickness, uterine position, cervical length, cervical diameter and for detection of any contraindications for IUD insertion.

Power Doppler Energy (PDE) measurement for subendometrial microvascularization will be done and categorized as women with minor subendometrial vascularization (Classifications I and II) and major subendometrial vascularization (Classifications III, IV and V)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients fulfilling the selection criteria undergo complete clinical examination and detailed medical history obtained. Each patient had a Case Record Form (CRF) recording participants' name. number, previous deliveries and abortions, age, height, weight, BMI, LMP, past medical and surgical history and contraceptive history.

\- All participants will be subjected to transvaginal ultrasound to measure uterine size, endometrial and myometrial thickness, uterine position, cervical length, cervical diameter and for detection of any contraindications for IUD insertion.

Power Doppler Energy (PDE) measurement for subendometrial microvascularization will be done and categorized as women with minor subendometrial vascularization (Classifications I and II) and major subendometrial vascularization (Classifications III, IV and V)

Only clinicians with proven proficiency in IUD insertion will be allowed to perform insertions.

* Perform a bimanual examination to determine the size, shape, and position of the uterus.
* Insert a warm, moistened speculum.
* Cleanse the cervix with an antiseptic solution.
* Open the sterile insertion instruments without touching the inside of the packet and place within easy reach.
* Remove the tenaculum by its handle and grasp the anterior or posterior lip of the cervix. Close gently to the first notch. Having the woman to cough while the tenaculum is being attached can ease the pinch.
* Apply gentle traction with the tenaculum to straighten the canal.
* Remove the sound by its handle and gently insert it to measure the depth of the uterus. Do not apply great force if there is resistance. Apply further traction to the tenaculum and attempt to re-insert the sound at a different angle. Once the sound is inserted and removed, note the depth of the uterine cavity. The woman can expect to feel cramping as the sound is inserted and withdrawn.
* Open the IUD pack without touching its contents.
* Put on sterile gloves.
* Load the IUD and insert it into the uterine cavity according to the manufacturer instructions. As the IUD is inserted through the cervix into the uterus, the patient may have pain and cramping similar to strong menstrual cramps.
* Gently remove the tenaculum. Tamponade any bleeding from the tenaculum site until it is resolved.
* Trim the strings of the IUD to 3-4 cm in length and note the string length. Avoid cutting the strings too short. If the client or her partner becomes aware of the threads, they may be cut shorter in length at the follow-up visit.
* Remove the speculum and assess the woman.
* Pain score will be assessed using Visual Analogue Scale:

1. Anticipated pain or current pain before the intervention.
2. Immediately after speculum insertion.
3. Immediately after tenaculum placement.
4. Immediately after uterine sounding.
5. During or immediately after IUD insertion.
6. Five minutes after the procedure

* Follow up at 3 and 6 months to assess women satisfaction with the method, menstrual pattern, symptoms of vaginal/pelvic infection Abdominal pain/tenderness Dyspareunia (woman/partner) Cramping or pregnancy.
* Vaginal examination to assess any infections or abnormalities and repeat ultrasound examination to assess the position of the IUD

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

IUCD Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

IUCD insertion
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IUD insertion

IUD insertion in women needing contraception

Group Type EXPERIMENTAL

IUD insertion

Intervention Type DEVICE

* Perform a bimanual examination
* Insert a warm, moistened speculum.
* Cleanse the cervix with an antiseptic solution.
* Open the sterile insertion instruments without touching
* Remove the tenaculum by its handle and grasp the anterior or posterior lip of the cervix.
* Apply gentle traction with the tenaculum to straighten the canal.
* Remove the sound by its handle and gently insert it to measure the depth of the uterus. Do not apply great force if there is resistance. Apply further traction to the tenaculum and attempt to re-insert the sound at a different angle. Once the sound is inserted and removed
* Open the IUD pack without touching its contents.
* Put on sterile gloves.
* Load the IUD and insert it into the uterine cavity according to the manufacturer instructions.
* Gently remove the tenaculum.
* Trim the strings of the IUD to 3-4 cm in length
* Remove the speculum and assess the woman.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IUD insertion

* Perform a bimanual examination
* Insert a warm, moistened speculum.
* Cleanse the cervix with an antiseptic solution.
* Open the sterile insertion instruments without touching
* Remove the tenaculum by its handle and grasp the anterior or posterior lip of the cervix.
* Apply gentle traction with the tenaculum to straighten the canal.
* Remove the sound by its handle and gently insert it to measure the depth of the uterus. Do not apply great force if there is resistance. Apply further traction to the tenaculum and attempt to re-insert the sound at a different angle. Once the sound is inserted and removed
* Open the IUD pack without touching its contents.
* Put on sterile gloves.
* Load the IUD and insert it into the uterine cavity according to the manufacturer instructions.
* Gently remove the tenaculum.
* Trim the strings of the IUD to 3-4 cm in length
* Remove the speculum and assess the woman.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 20 -41 years
* BMI 18-25 kg/m2
* Women with any parity seeking contraception and choosing IUD as their preferred method after proper and thorough counseling
* Regularly menstruating women (duration of menstruation 3-7 days and length of cycle 22- 35 days).
* Not using any hormonal therapy or anticoagulation

Exclusion Criteria

* Cervical abnormalities.
* Pregnancy or suspicion of pregnancy
* Congenital or acquired uterine anomalies which distort the uterine cavity (fibroids, endometrial polyps, cervical stenosis, bicornuate uterus, hypoplastic uterus \< 6 cm)
* Acute PID or a history of PID within the past 3 months
* Postpartum or post-abortion endometritis within the past 3 months
* Current STI or within the past 3 months (including cervicitis)
* Cervical cancer
* Endometrial cancer
* Malignant gestational trophoblastic disease
* Undiagnosed vaginal bleeding
* Hypersensitivity to any component in the IUD (copper)
* Less than 6 weeks postpartum.
* Neurological or psychological conditions that may affect pain sensation
Minimum Eligible Age

20 Years

Maximum Eligible Age

41 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed M Maged, MD

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahmed Maged

Role: PRINCIPAL_INVESTIGATOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kasr Alainy medical school

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed Maged

Role: CONTACT

+201005227404

Ahmed chamel

Role: CONTACT

+20 110 066 2255

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed Maged, MD

Role: primary

01005227404

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N 362

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Novel IUD Insertion Technique
NCT02582268 UNKNOWN NA
PostPlacental IUD Insertion
NCT02679820 COMPLETED NA